PIK3CA and neoplasm: Moreover, Fink et al. found that gene expression profiles for TNBC subtype definition were poor predictors of response to kinase inhibitors, whereas high sensitivity was reported when treatment options were based on specific genetic abnormalities of tumor, such as PTEN loss or PIK3CA mutations [59].